Reading MPT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MPT free→Reading MPT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MPT free→
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-06-12
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is weak, and the company was unprofitable over the past year, so its earnings quality can't be assessed. Risk is moderate, and compared with sector peers, MPT is below typical for the sector. Peer multiples imply a price about 54% above where it trades (it looks cheap on this basis); the read is cheap, value-trap risk, as it trades below peer multiples, but recent financials are weak or earnings quality is fragile, historically a value-trap pattern. If MPT cuts guidance on the next call, that could be a meaningful negative. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 1 valuation methods, at three horizons. Current price $4.96. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $4.96 MPT trades at 3× p/s, below its 6× p/s peer median. Our $11 fair value sits above the price; low confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price sits about 54% below a flat-multiple fair value; not enough history to forecast a comparison. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
Only a turbulent sector regime (Heating) — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Real Estate names rated weak grew net income 56% of the time over the next year (vs 55% for the rest of the cohort, n=1506).
Over the trailing year it converted -0.80x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
Not enough signal yet.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.01 → $0.00 (-100.0% / 30d). 0 raised, 1 cut, 1 covering analysts.
0 upgrades, 0 downgrades / 30d. 33% of analysts rate Buy.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$121.
How much price usually moves either way.
On a bad day, this stock has moved -$305.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,340.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Earnings results will provide insight into financial health and cash rent progress.
Confirms one read:Earnings results show good cash flow. Financial metrics are also better.
Confirms the other:Earnings results show bad cash flow. Financial metrics are getting worse.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for MPT yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition. On April 30, 2026, Medical Properties Trust, Inc. issued a press release announcing its financial results for the three months ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the information set forth in Exhibit 99.1 and Exhibit 99.2 attached hereto, shall not be deemed “filed” for…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
A side-by-side read on sector standing, valuation, and risk versus Health Care REITs.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
MPT Medical Properties Trust | Below typical Show detailsSector percentile: 25 of 100 | inexpensive | moderate |
WELL Welltower | Typical Show detailsSector percentile: 58 of 100 | expensive | low |
VTR Ventas | Typical Show detailsSector percentile: 31 of 100 | expensive | moderate |
OHI Omega Healthcare Investors | Typical Show detailsSector percentile: 63 of 100 | expensive | moderate |
DOC Healthpeak Properties | Above typical Show detailsSector percentile: 72 of 100 | fair | moderate |
Not investment advice. As of 2026-06-12.
via XLRE
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Management aims to reach $1 billion in annualized cash rent from the current portfolio by the end of 2026.
Why it matters: If revenue growth speeds up, it may signal a shift in the maturing real estate sector. This could benefit MPT.
Confirms:Sector revenue growth exceeds 3% year over year.
Disproves:Sector revenue growth remains below 1% year over year.
Why it matters: The earnings report will show if the company can improve its financial condition. Investors will look for signs of recovery.
Confirms one read:Earnings report shows funds from operations (FFO) growth of more than 5% year over year.
Confirms the other:Earnings report shows FFO decline of more than 5% year over year.
Why it matters: Hitting this target is important for growth. It shows how well management is doing.
Confirms:Q2 cash rent reported at or above $250 million, indicating strong progress.
Disproves:Q2 cash rent reported below $200 million, showing lack of progress.